Skip to main content
OpenTrials

Clinical trial condition

NSCLC (Non-small Cell Lung Cancer)

Explore clinical trials studying NSCLC (Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.

53 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

NSCLC (Non-small Cell Lung Cancer) trial results

Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 152 locations
View Trial Details
Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130

Conditions
Advanced or Metastatic Solid Tumors, Brain Diseases, Brain Neoplasms, +41 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Phase I Clinical Trials Unit Birmingham, Alabama, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

Study of XB010 in Subjects With Solid Tumors

NCT06545331

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

NCT06835569

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC (Colorectal Cancer), +33 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site St Louis, Missouri, United States
View Trial Details

Related conditions